Literature DB >> 3306264

High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 beta.

J J Huang, R C Newton, K Pezzella, M Covington, T Tamblyn, S J Rutlege, J Gray, M Kelley, Y Lin.   

Abstract

A complementary DNA sequence encoding monocyte interleukin-1 (IL-1), beta form/pI7, was expressed in Escherichia coli. Recombinant plasmid pDP516 was constructed by cloning and rebuilding the mature IL-1 coding sequence into an E. coli expression vector. Bacteria transformed with pDP516 constitutively produced recombinant IL-1 (r-IL-1) at 15-20% of total E. coli protein. The r-IL-1 was found to be in the soluble fraction of sonicated E. coli Bacterial r-IL-1 (DP516) has been purified to homogeneity by anion exchange and sizing column chromatography, with an apparent molecular weight of 17,500. The identity of the purified r-IL-1 was confirmed by amino acid and DNA sequencing analyses. Purified recombinant IL-1 DP516 exhibits biological activity similar to that of native monocyte IL-1 (3 approximately 4 X 10(7) units/mg). An amino-terminal deletion mutant completely abolishes the biological activity, indicating that the integrity of the IL-1 molecule might be important for its function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306264

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  8 in total

1.  The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression.

Authors:  R Horuk; J A McCubrey
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

2.  Effects of IL-1 muteins on cartilage degradation and as inducers of acute inflammation.

Authors:  M A Pratta; E C Arner; B L Rule; W Galbraith
Journal:  Agents Actions       Date:  1991-09

3.  In vivo studies on the effects of human recombinant interleukin-1 beta on articular cartilage.

Authors:  E C Arner; T M Di Meo; D M Ruhl; M A Pratta
Journal:  Agents Actions       Date:  1989-06

4.  Effect of interleukin-1-beta and tumor necrosis factor-alpha on cartilage proteoglycan metabolism in vitro.

Authors:  M A Pratta; T M Di Meo; D M Ruhl; E C Arner
Journal:  Agents Actions       Date:  1989-06

5.  Isothiazolones interfere with normal matrix metalloproteinase activation and inhibit cartilage proteoglycan degradation.

Authors:  E C Arner; M A Pratta; B Freimark; M Lischwe; J M Trzaskos; R L Magolda; S W Wright
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity.

Authors:  R J North; R H Neubauer; J J Huang; R C Newton; S E Loveless
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

7.  Differences in internalization and intracellular processing of interleukin-1 associated with the two forms of interleukin-1 receptor found in B-cells and T-cells.

Authors:  R Horuk
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

8.  IL-1 and its role in rat carrageenan pleurisy.

Authors:  R Goodman; L R Mantegna; C L McAilister; E Bruin; R L Dowling; H George; W Feeser; B Freimark; M Lischwe; S Pick; R R Harris; J S Kerr
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.